Skip to main content

Animations

MJFF Publications

1371 - 1380 of 8808 Results
Title
Year
  • Year
  • 2020
  • 2020
  • 2019
  • 2019
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • Summary Details
    OPEN
    Title: Assessment of Demographic, Genetic, and Imaging Variables Associated With Brain Resilience and Cognitive Resilience to Pathological Tau in Patients With Alzheimer Disease
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2019.5154
    Citation Count: 127
  • Summary Details
    RESTRICTED
    Title: Time for a New Image of Parkinson Disease
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2020.2412
    Citation Count: 45
  • Summary Details
    OPEN
    Title: Freezing of Gait and Its Levodopa Paradox
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2019.4006
    Citation Count: 51
  • Summary Details
    RESTRICTED
    Title: The Narrowing Path for Nilotinib and Other Potential Disease-Modifying Therapies for Parkinson Disease
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2019.3983
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Seven-Year Experience From the National Institute of Neurological Disorders and Stroke–Supported Network for Excellence in Neuroscience Clinical Trials
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2020.0367
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Choosing a Parkinson Disease Treatment
    Journal Name: JAMA
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jama.2020.1224
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Palliative Care for Persons Living With Parkinson Disease
    Journal Name: JAMA
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jama.2020.18333
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders
    Journal Name: JAMA
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jama.2020.12134
    Citation Count: 1060
  • Summary Details
    OPEN
    Title: Amyloid-like oligomerization of AIMP2 contributes to α-synuclein interaction and Lewy-like inclusion
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.aax0091
    Citation Count: 21
  • Summary Details
    RESTRICTED
    Title: A patient-based model of RNA mis-splicing uncovers treatment targets in Parkinson’s disease
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.aau3960
    Citation Count: 41
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.